telmesteine has been researched along with Dermatitis, Atopic in 1 studies
*Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abramovits, W; Boguniewicz, M | 1 |
1 trial(s) available for telmesteine and Dermatitis, Atopic
| Article | Year |
|---|---|
A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP (Atopiclair) in the management of mild to moderate atopic dermatitis in adults.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Colorado; Dermatitis, Atopic; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Glycyrrhetinic Acid; Humans; Hyaluronic Acid; Male; Middle Aged; Plant Extracts; Severity of Illness Index; Texas; Thiazoles; Thiazolidines; Treatment Outcome; Vitis | 2006 |